Pure Biologics

Pure Biologics Long-term Debt

Long-Term Debt of Pure Biologics (PUR.WA) as of Nov 12, 2026.

Long-term Debt

0.00PLN

Last updated:

Long-Term Debt of Pure Biologics is 2025 0.00 PLN. Long-Term Debt of Pure Biologics was 2024 0.00 PLN. It decreases by % lower compared to the previous year.

The Pure Biologics Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2018
446,117.73 PLN
Jan 1, 2019
2.54 M PLN
Jan 1, 2022
0.00 PLN
Jan 1, 2023
12.72 M PLN
Jan 1, 2024
0.00 PLN
Jan 1, 2025
0.00 PLN
The Pure Biologics Long-term Debt history
YEARLong-term DebtYoY
0.00PLN—
0.00PLN-100.00%
12.72 MPLN—
0.00PLN-100.00%
2.54 MPLN+469.97%
446,117.73PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics SA, headquartered in Wrocław, Poland, operates in the Health Care sector as a biotechnology company. It focuses on research and development of innovative biological medicines and medical devices for therapeutic and diagnostic applications. The company employs 53 full-time staff and was listed on the stock market on 11 December 2018. Founded in August 2010, it remains based in Wrocław, focusing on biopharmaceutical solutions. Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

On Eulerpool you can find the complete historical development of Long-Term Debt Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Pure Biologics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Pure Biologics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Pure Biologics